CW June 2002Issue Number 6 June 2002 ISSN 10593802 Targeted Therapy Shrinks Advanced Lung CancerAnother daily oral therapy targeted at tyrosine kinase, gefitinib (Iressa), can help shrink lung tumors and ease suffering for advanced cancer patients. It may provide a new way to fight lung cancer.
Go to Previous Page Go to Next Page Source & Additional Reading ASCO Annual Meeting, Orlando. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW June 2002Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |